Jennifer Peterson
Dermatology · Houston, TXNPI 1164614913
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,540 of the $66,287 with a category attached, or 70.2%. Galderma Laboratories, L.p. accounts for 67.0% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $32,708 and has fallen 93.1% since, to $2,253 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 363 payments — averaging $182.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$44K
- Merz North America, Inc.$9K
- Lumenis, Inc$7K
- AbbVie$3K
- Johnson & Johnson$442
- Almirall LLC$402
- plus $2K from 25 others
Across 15 payments — averaging $5600.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz North America, Inc.$66K
- Endo Pharmaceuticals Inc.$18K
What the payments were for
- Consulting fees$7,44111%
- Speaking & faculty fees$46,54070%
- Travel & lodging$3,1215%
- Food & beverage$9,06914%
- Education$1160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 93 | $44,383 |
| Merz North America, Inc. | 23 | $8,678 |
| Lumenis, Inc | 2 | $7,000 |
| AbbVie(2 entities) | 85 | $2,920 |
| Johnson & Johnson | 21 | $442 |
| Almirall LLC | 19 | $402 |
| Incyte Corporation | 11 | $325 |
| Arcutis Biotherapeutics, Inc. | 13 | $302 |
| Mayne Pharma Commercial LLC | 11 | $226 |
| Amgen | 9 | $216 |
| Pfizer | 11 | $209 |
| Regeneron Healthcare Solutions, Inc. | 5 | $146 |
| Encore Dermatology Inc. | 13 | $129 |
| Novartis | 8 | $129 |
| LEO Pharma Inc. | 7 | $129 |
| UCB, Inc. | 4 | $102 |
| Verrica Pharmaceuticals Inc. | 5 | $99 |
| E.r. Squibb & Sons, L.L.C. | 4 | $83 |
| Sanofi | 2 | $59 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $48 |
| Dermira, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| VYNE Pharmaceuticals Inc. | 2 | $39 |
| Bristol Myers Squibb | 1 | $22 |
| EPI Health, LLC | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $17 |
| Journey Medical Corporation | 1 | $13 |
| Organon | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$66,287 in reported general payments places this provider in the 90th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 17 | $959 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Houston
- Alpesh DesaiHouston$1.6M
- Geeta PatelHouston$575K
- Michael MigdenHouston$310K
- Catherine PapasakelariouHouston$289K
- Stephen MahoneyHouston$137K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.